Global Remote Healthcare Market Overview:
Increased patient, payer, and provider adoption of remote healthcare technologies. During the epidemic, many people used real-time virtual health systems to avoid visiting hospitals. The market is expected to develop due to the usage of real-time virtual health services such as audio, video, and chatbox. Globally, the market is expected to be driven by increasing adoption of smartphones, mHealth apps, wearable technologies, and digital healthcare. Furthermore, the remote healthcare industry is seeing an increase in investment, which is fueling segment growth.
Growth Drivers
- Increasing adoption of real-time virtual health services such as audio, video, and chatbox
- Increasing adoption of smartphones, mHealth apps, wearable technologies, and digital healthcare
Roadblocks
- Regulatory variations across regions
Opportunities
- Rising acceptance of remote healthcare services by insurance companies
- Role and impact of AI in remote patient monitoring
Challenges
Competitive Landscape:
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Some of the key players profiled in the report are Advanced ICU Care (United States), BioTelemetry (United States), Koninklijke Philips N.V. (Netherlands), Teladoc Health (United States), Vivify Health (United States), AirStrip Technologies (United States), Medtronic (Ireland), InTouch Technologies (United States), American Well (United States) and Resideo Life Care Solutions (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Remote Healthcare market by 2026. Considering Market by End User, the sub-segment i.e. Payer will boost the Remote Healthcare market.
Latest Market Insights:
In February 2021, Phillips acquired BioTelemetry, Inc., a provider of remote cardiac monitoring devices and services to expand its patient care management segment product portfolio. and In May 2021, MediTelecare, a telehealth technology provider launched MediTely, direct-to-consumer mobile telehealth technology for the geriatric population.
In March 2020, Sheba Medical Center and the Ichilov Hospital in Israel introduced AI-based tele-ICUs for supporting COVID-19 patients., and In March 2020, Doctor Anywhere, telehealth and real-time virtual health platform raised USD 27.0 million in a Series B financing round.
What Can be Explored with the Remote Healthcare Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Remote Healthcare Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Remote Healthcare
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Remote Healthcare market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Remote Healthcare market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants and Investors, Remote Healthcare Provider, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.